Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...
L&T Technology Services has launched an AI-based lung digital twin platform designed for lung navigation, surgical planning, ...
Policymakers propose AI solutions as being potentially transformative for the NHS in England, but there is limited robust, ...
Morning Overview on MSN
Scientists scanned 2,000 ants to build a 3D database
An international team of researchers has built the largest three-dimensional database of ant anatomy ever assembled, scanning ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found.
The microscopy expert put the big-clawed animal through his micro-CT scanner, creating an incredibly detailed image of its ...
A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving ...
Smiths Detection, a global leader in threat detection and screening solutions, today announces the sale of its 2,000th ...
ASX health imaging firms see AI as opportunity, not threat, with growth potential intact despite recent sell down in software stocks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results